|
|
Volumn 66, Issue 10, 2009, Pages 880-882
|
|
FDA advisers wary of expanding quetiapine use
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLUCOSE;
QUETIAPINE;
SEROQUEL XR;
UNCLASSIFIED DRUG;
BIPOLAR DISORDER;
DRUG EFFICACY;
DRUG SAFETY;
DYSLIPIDEMIA;
FOOD AND DRUG ADMINISTRATION;
GENERALIZED ANXIETY DISORDER;
GLUCOSE BLOOD LEVEL;
HUMAN;
MAJOR DEPRESSION;
METABOLIC DISORDER;
MONOTHERAPY;
NOTE;
PREVALENCE;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
SIDE EFFECT;
SUDDEN DEATH;
TARDIVE DYSKINESIA;
WEIGHT GAIN;
|
|
EID: 65649121219
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news090042 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|